Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer

Reference

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Fraguas-Sanchez AI, Martin-Sabroso C, Fernandez-Carballido A, et al. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemother Pharmacol. 2019;84:689–706.
   PubMed Web of Science ®Google Scholar
• Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–1281.
   PubMed Web of Science ®Google Scholar
• Bakker A, van der Zee J, van Tienhoven G, et al. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review. Int J Hyperthermia. 2019;36(1):1024–1039.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and Meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–1087.
   PubMed Web of Science ®Google Scholar
• Dharmaiah S, Zeng J, Rao VS, et al. Clinical and dosimetric evaluation of recurrent breast cancer patients treated with hyperthermia and radiation. Int J Hyperthermia. 2019;36(1):986–992.
   PubMed Web of Science ®Google Scholar
• Oldenborg S, van Os R, Oei B, et al. Impact of technique and schedule of reirradiation plus hyperthermia on outcome after surgery for patients with recurrent breast cancer. Cancers. 2019;11(6):782.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497.
   PubMed Web of Science ®Google Scholar
• van der Zee J. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173–1184.
   PubMed Web of Science ®Google Scholar
• Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia. 1986;2(2):111–137.
   PubMedGoogle Scholar
• Habash RW, Bansal R, Krewski D, et al. Thermal therapy, part 2: hyperthermia techniques. Crit Rev Biomed Eng. 2006;34(6):491–542.
   PubMedGoogle Scholar
• Mundhara N, Majumder A, Panda D. Hyperthermia induced disruption of mechanical balance leads to g1 arrest and senescence in cells. Biochem J. 2021;478(1):179–196.
   PubMed Web of Science ®Google Scholar
• Sola-Leyva A, Jabalera Y, Chico-Lozano MA, et al. Reactive oxygen species (ros) production in hepg2 cancer cell line through the application of localized alternating magnetic field. J Mater Chem B. 2020;8(34):7667–7676.
   PubMed Web of Science ®Google Scholar
• Yuen WF, Fung KP, Lee CY, et al. Hyperthermia and tumour necrosis factor-alpha induced apoptosis via mitochondrial damage. Life Sci. 2000;67(6):725–732.
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dynlacht JR, Dikomey E. Mechanism of radiosensitization by hyperthermia (> or = 43 degrees c) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia. 2004;20(2):131–139.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, et al. Hyperthermia on immune regulation: a temperature’s story. Cancer Lett. 2008;271(2):191–204.
   PubMed Web of Science ®Google Scholar
• Liu X, Zheng J, Sun W, et al. Ferrimagnetic vortex nanoring-mediated mild magnetic hyperthermia imparts potent immunological effect for treating cancer metastasis. ACS Nano. 2019;13(8):8811–8825.
   PubMed Web of Science ®Google Scholar
• Wang R, He Z, Cai P, et al. Surface-functionalized modified copper sulfide nanoparticles enhance checkpoint blockade tumor immunotherapy by photothermal therapy and antigen capturing. ACS Appl Mater Interfaces. 2019;11(15):13964–13972.
   PubMed Web of Science ®Google Scholar
• Oei AL, Kok HP, Oei SB, et al. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Adv Drug Deliv Rev. 2020;163–164:84–97.
   PubMed Web of Science ®Google Scholar
• Aigner A. Applications of rna interference: current state and prospects for sirna-based strategies in vivo. Appl Microbiol Biotechnol. 2007;76(1):9–21.
   PubMed Web of Science ®Google Scholar
• Lv MM, Zhu XY, Chen WX, et al. Exosomes mediate drug resistance transfer in mcf-7 breast cancer cells and a probable mechanism is delivery of p-glycoprotein. Tumour Biol. 2014;35(11):10773–10779.
   PubMedGoogle Scholar
• Otsuka K, Yamamoto Y, Ochiya T. Uncovering temperature-dependent extracellular vesicle secretion in breast cancer. J Extracell Vesicles. 2020;10(2):e12049.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The string database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Lee SM, Ahn RW, Chen F, et al. Biological evaluation of ph-responsive polymer-caged nanobins for breast cancer therapy. ACS Nano. 2010;4(9):4971–4978.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43(1):33–56.
   PubMed Web of Science ®Google Scholar
• Hu W, Xu Z, Zhu S, et al. Small extracellular vesicle-mediated hsp70 intercellular delivery enhances breast cancer adriamycin resistance. Free Radic Biol Med. 2021;164:85–95.
   PubMed Web of Science ®Google Scholar
• Bachurski D, Schuldner M, Nguyen PH, et al. Extracellular vesicle measurements with nanoparticle tracking analysis - an accuracy and repeatability comparison between nanosight ns300 and zetaview. J Extracell Vesicles. 2019;8(1):1596016.
   PubMed Web of Science ®Google Scholar
• Szatanek R, Baj-Krzyworzeka M, Zimoch J, et al. The methods of choice for extracellular vesicles (evs) characterization. Int J Mol Sci. 2017;18(6):1153.
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228.
   PubMed Web of Science ®Google Scholar
• Fu C, Zhang Q, Wang A, et al. Ewi-2 controls nucleocytoplasmic shuttling of egfr signaling molecules and mirna sorting in exosomes to inhibit prostate cancer cell metastasis. Mol Oncol. 2021;15(5):1543–1565.
   PubMed Web of Science ®Google Scholar
• Wu S, Luo M, To KKW, et al. Intercellular transfer of exosomal wild type egfr triggers osimertinib resistance in non-small cell lung cancer. Mol Cancer. 2021;20(1):17.
   PubMed Web of Science ®Google Scholar
• Wang X, Chai Z, Pan G, et al. Exobcd: a comprehensive database for exosomal biomarker discovery in breast cancer. Brief Bioinform. 2020;22(3):bbaa088.
   Web of Science ®Google Scholar
• Sinha D, Roy S, Saha P, et al. Trends in research on exosomes in cancer progression and anticancer therapy. Cancers. 2021;13(2):326.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma Z, Liu Y, et al. Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model. Febs J. 2016;283(15):2836–2852.
   PubMed Web of Science ®Google Scholar
• Sun WL, Lan D, Gan TQ, et al. Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells. Neoplasma. 2015;62(2):199–208.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li C, Li H, et al. Resveratrol-mediated reversal of tumor multi-drug resistance. Curr Drug Metab. 2014;15(7):703–710.
   PubMed Web of Science ®Google Scholar
• Nowak R, Tarasiuk J. The inhibition of apoptosis in cancer cells resistant to anticancer drugs. Postepy Biochem. 2004;50(4):330–343.
   PubMedGoogle Scholar
• Seynhaeve ALB, Amin M, Haemmerich D, et al. Hyperthermia and smart drug delivery systems for solid tumor therapy. Adv Drug Deliv Rev. 2020;163–164:125–144.
   PubMed Web of Science ®Google Scholar
• Li J, Wang DD, Zhao YN, et al. Clinical assessment of magnetic resonance imaging-guided radiofrequency ablation for breast cancer. Mol Clin Oncol. 2019;11(4):411–415.
   PubMed Web of Science ®Google Scholar
• Ozanne BW, Spence HJ, McGarry LC, et al. Transcription factors control invasion: Ap-1 the first among equals. Oncogene. 2007;26(1):1–10.
   PubMed Web of Science ®Google Scholar
• Sundqvist A, Voytyuk O, Hamdi M, et al. Jnk-dependent cjun phosphorylation mitigates tgfbeta- and egf-induced pre-malignant breast cancer cell invasion by suppressing ap-1-mediated transcriptional responses. Cells. 2019;8(12):1481.
   PubMed Web of Science ®Google Scholar
• Kurozumi S, Joseph C, Sonbul S, et al. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer. Br J Cancer. 2019;120(12):1129–1136.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fu X, Guan Y, et al. 1,3-dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through il6/jak2/pi3k pathway. Biochem Pharmacol. 2020;172:113752.
   PubMed Web of Science ®Google Scholar
• McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18(1):52.
   PubMed Web of Science ®Google Scholar
• Hugel B, Martinez MC, Kunzelmann C, et al. Membrane microparticles: two sides of the coin. Physiology. 2005; 20:22–27.
   PubMed Web of Science ®Google Scholar
• Guerra F, Bucci C. Multiple roles of the small gtpase rab7. Cells. 2016;5(3):34.
   PubMed Web of Science ®Google Scholar
• Progida C, Cogli L, Piro F, et al. Rab7b controls trafficking from endosomes to the tgn. J Cell Sci. 2010;123(Pt 9):1480–1491.
   PubMed Web of Science ®Google Scholar
• Cesi G, Philippidou D, Kozar I, et al. A new alk isoform transported by extracellular vesicles confers drug resistance to melanoma cells. Mol Cancer. 2018;17(1):145.
   PubMed Web of Science ®Google Scholar
• Bellavia D, Raimondo S, Calabrese G, et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth. Theranostics. 2017;7(5):1333–1345.
   PubMed Web of Science ®Google Scholar